Extrapyramidal symptoms in patients treated with risperidone.
about
Haloperidol versus placebo for schizophreniaAntipsychotic medication for early episode schizophreniaRisperidone dose for schizophreniaRisperidone versus placebo for schizophreniaHaloperidol versus placebo for schizophreniaNovel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.Haloperidol versus placebo for schizophrenia.Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trialCost comparisons of olanzapine and risperidone in treating schizophrenia.Atypical Antipsychotic Use in the Treatment of Psychosis in Primary CareRisk:benefit assessment of old medicines.Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs.Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders.Metabolic drug interactions with newer antipsychotics: a comparative review.Polypharmacy in the management of patients with schizophrenia on risperidone in a tertiary-care hospital in MalaysiaA systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone.Incidence and time course of extrapyramidal symptoms with oral and long-acting injectable paliperidone: a posthoc pooled analysis of seven randomized controlled studies.How can research ethics committees protect patients better?Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression.Treatment of mixed mania with risperidone and mood stabilizers.Effects of risperidone on gonadal axis hormones in schizophrenia.A naturalistic study of risperidone treatment in seven affiliated university hospitals in Korea.Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.Risperidone versus placebo for schizophrenia
P2860
Q24202457-0EE30EDC-D8B1-4CEA-9D8A-74EBE83D641DQ24236683-AF358FE5-FB7D-4456-BBA6-D1151E5F06D1Q24240095-8A3F59A8-DB48-4456-9046-92750C3B005EQ24241041-5EDEB94C-53E5-468F-A8F0-376E508FD734Q24243823-CC230216-B1CA-478E-AB88-60286FCB79B6Q30501297-2AC70EC6-256F-4A74-B661-3B49F66E5005Q30992683-3A9A6764-2270-4FD9-8AB4-4DBB0BD5A10AQ34480263-27D011BE-7D26-4E5F-8995-39780BEBC2C9Q35638077-D0B71F63-B562-4272-992B-B6FD02F2BBF6Q35665593-55252DCD-FEBF-4D4C-9DB5-1E4CA5EFF633Q35826523-0E494DA4-E125-41A5-B900-AE897C55B773Q36209662-7F98D381-1D5F-4153-8170-A5006AB981B4Q36346334-77158EB1-143E-494B-83C6-EA336E8DBAD1Q36700337-6B93DDC6-93D9-4F8C-BDA3-36D2B46A2D18Q36703845-D004D6ED-DC1C-4952-9F48-96B6809C6727Q37294192-C8A32180-3521-414F-B5BE-13CCE87AEA13Q38682742-C9C53982-A16C-4614-AED7-A490E5C858BBQ41862402-B0C707A5-AFCB-4F19-98CF-6A54C9F8E4B0Q42084184-8F6D6A69-C197-4692-A5DB-BB75403B824DQ42771386-B36F2E77-52FF-4B1A-966B-65166B28BE7AQ43836565-B63DA417-5697-4211-AAD1-39D2423DD912Q43856238-C526E525-C35E-4193-852D-78233DEE2C99Q44272988-F6E5A3AE-7C50-4B14-81BE-1E3CB7870C1FQ45172279-BD30CAF3-1039-4258-BDDA-72FF3A330FDEQ46486034-DF0F9965-99C2-4C11-A860-805DE677CCF5Q55894951-EA7E4FD9-1D07-4011-9082-9C1707DECB18
P2860
Extrapyramidal symptoms in patients treated with risperidone.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Extrapyramidal symptoms in patients treated with risperidone.
@en
Extrapyramidal symptoms in patients treated with risperidone.
@nl
type
label
Extrapyramidal symptoms in patients treated with risperidone.
@en
Extrapyramidal symptoms in patients treated with risperidone.
@nl
prefLabel
Extrapyramidal symptoms in patients treated with risperidone.
@en
Extrapyramidal symptoms in patients treated with risperidone.
@nl
P1476
Extrapyramidal symptoms in patients treated with risperidone.
@en
P2093
Lindenmayer JP
Simpson GM
P304
P356
10.1097/00004714-199706000-00010
P407
P577
1997-06-01T00:00:00Z